Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of AJU-C711 vs C711R in Healthy Adults
NCT06931327Phase 1Completed
- Sponsor
- AJU PHARM Co., Ltd.
- Start
- Mar 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ezetimibe + pitavastatin calcium in hypercholesterolemia (2 arms), sponsored by AJU PHARM Co., Ltd. Primary endpoints: Area Under the Concentration-Time Curve from time zero to the last quantifiable concentration and Maximum Plasma Concentration. Started Mar 2025; status: completed.
02
Drugs
ezetimibe + pitavastatin calcium
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT06931327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06931327.